Renal sympathetic denervation for resistant hypertension: Where do we stand after more than a decade

13Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Despite the current availability of safe and efficient drugs for treating hypertension, a substantial number of patients are drug-resistant hypertensives. Aiming this condition, a relatively new approach named catheter-based renal denervation was developed. We have now a clinically relevant time window to review the efficacy of renal denervation for treating this form of hypertension. This short review addresses the physiological contribution of renal sympathetic nerves for blood pressure control and discusses the pros and cons of renal denervation procedure for the treatment of resistant hypertension.

Cite

CITATION STYLE

APA

Fontes, M. A. P., Marzano, L. A. S., Silva, C. C., & Silva, A. C. S. E. (2020, March 1). Renal sympathetic denervation for resistant hypertension: Where do we stand after more than a decade. Brazilian Journal of Nephrology. Sociedade Brasileira de Nefrologia. https://doi.org/10.1590/2175-8239-JBN-2018-0213

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free